Mutations in NPM1, the gene encoding the nucleolar phosphoprotein nucleophosmin, have been considered early events in de novo AML, largely because of their stability through the disease course and their mutual exclusivity with chromosomal translocations, the best-established type of initiating mutation. The gene discussed is NPM1; the disease is acute myeloid leukemia.